measure development as specified in section 918, in-
cluding data related to racial, ethnic, and language 
attributes; gender, age, geography, and socio-
economic conditions; the specificity, interoperability, 
and socio-technical aspects of electronic vocabularies 
and ontologies related to presenting symptoms and 
diagnostic certainty; and the development and use of 
symptom-based clinical registries. Such panel shall 
consider enhanced data capabilities that are nec-
essary to support both research and improvement of 
diagnostic safety and quality.’’. 
SEC. 6. INTERAGENCY COUNCIL ON IMPROVING DIAGNOSIS 
IN HEALTH CARE. 
(a) ESTABLISHMENT.—The Secretary of Health and 
Human Services (in this section referred to as the ‘‘Sec-
retary’’) shall establish within the Office of the Secretary 
an interagency council to be known as the Interagency 
Council on Improving Diagnosis in Health Care (referred 
to in this section as the ‘‘Council’’). 
(b) OBJECTIVES.—The Council shall furnish a forum 
for the agencies represented on the Council to discuss 
ways to accomplish the following objectives: 
(1) Enhance the quality, appropriateness, and 
effectiveness of diagnosis in health care through— 
VerDate Sep 11 2014 
16:30 Jul 03, 2022
Jkt 029200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H8172.IH
H8172
pbinns on DSKJLVW7X2PROD with $$_JOB
(A) the establishment and support of a 
broad base of scientific research; 
(B) the dissemination and implementation 
of the results of such research; and 
(C) the promotion of improvements in clin-
ical and health system practices. 
(2) Identify and eliminate systemic barriers to 
supporting research in improving diagnosis in health 
care. 
(3) Identify knowledge gaps, research and data 
needs, and opportunities congruent with agency mis-
sions to strengthen the clinical and translational re-
search pipeline to improve diagnostic safety and 
quality, including potential collaborative research ini-
tiatives among 2 or more agencies, offices, institutes, 
or centers within the Department of Health and 
Human Services or other Federal agencies or offices. 
(c) MEMBERSHIP.— 
(1) CHAIRPERSON.—The Director of the Agen-
cy for Healthcare Research and Quality (or the Di-
rector’s designee) shall be the Chairperson of the 
Council. 
(2) MEMBERS.— 
VerDate Sep 11 2014 
16:30 Jul 03, 2022
Jkt 029200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H8172.IH
H8172
pbinns on DSKJLVW7X2PROD with $$_JOB
(A) IN
GENERAL.—In addition to the 
Chairperson, the Council shall be comprised of 
the following: 
(i) At least 1 designee from each of 
the following, appointed by the head of the 
applicable department or agency: 
(I) The Centers for Disease Con-
trol and Prevention. 
(II) The Centers for Medicare & 
Medicaid Services. 
(III) The Department of Vet-
erans Affairs. 
(IV) The Congressionally Di-
rected Medical Research Program of 
the Department of Defense. 
(V) The Office of the National 
Coordinator for Health Information 
Technology. 
(ii) Designees from the National Insti-
tutes of Health, including a least 1 des-
ignee from each of the following: 
(I) The National Cancer Insti-
tute. 
(II) The National Center for Ad-
vancing Translational Sciences. 
VerDate Sep 11 2014 
16:30 Jul 03, 2022
Jkt 029200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H8172.IH
H8172
pbinns on DSKJLVW7X2PROD with $$_JOB
(III) The National Institute of 
Allergy and Infectious Diseases. 
(IV) The National Heart, Lung, 
and Blood Institute. 
(V) The National Institute of 
Neurological Disorders and Stroke. 
(VI) The National Library of 
Medicine. 
(VII) The National Institute on 
Minority Health and Health Dispari-
ties. 
(VIII) The National Institute of 
Nursing Research. 
(IX) The Eunice Kennedy Shriv-
er National Institute of Child Health 
and Human Development. 
(iii) Designees from such other na-
tional research institutes and national cen-
ters as may be appropriate, as determined 
by the Director of the National Institutes 
of Health. 
(B) ADDITIONAL MEMBERS.—In addition 
to the designees under subparagraph (A), the 
Council may include such other designees from 
VerDate Sep 11 2014 
16:30 Jul 03, 2022
Jkt 029200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H8172.IH
H8172
pbinns on DSKJLVW7X2PROD with $$_JOB
Federal departments or agencies as the Chair-
person of the Council deems appropriate. 
(C) DESIGNATION.—A person appointed to 
the Council as a designee shall be a senior offi-
cial or employee of the department or agency 
whose responsibilities and subject matter exper-
tise are relevant to the Council’s objectives list-
ed in subsection (b), as determined by the des-
ignating official. 
(d) STRATEGIC PLAN; REPORTS.— 
(1) STRATEGIC FEDERAL PLAN TO IMPROVE DI-
AGNOSIS
IN
HEALTH
CARE.—Not later than 18 
months after the date of enactment of this Act, the 
Council shall develop, submit to the Secretary and 
Congress, and make publicly available a strategic 
plan, to be known as the Strategic Federal Plan to 
Improve Diagnosis. Consistent with the objectives 
listed in subsection (b), such strategic plan— 
(A) shall identify coordinated opportunities 
to enhance scientific research and reduce sys-
temic barriers in order to improve diagnosis in 
health care; and 
(B) shall include administrative policy rec-
ommendations, and may include such legislative 
recommendations as the Council may wish to 
VerDate Sep 11 2014 
16:30 Jul 03, 2022
Jkt 029200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H8172.IH
H8172
pbinns on DSKJLVW7X2PROD with $$_JOB
make, including recommendations on opportuni-
ties to remove barriers to, and enhance, inter-
agency coordination in the planning, conduct, 
and funding of, such research. 
(2) REPORTS TO CONGRESS.—Not later than 
July 31 of every odd-numbered year beginning with 
the first such year after the date of submission of 
the first Strategic Federal Plan to Improve Diag-
nosis under paragraph (1), the Council shall pre-
pare, submit to the Secretary and Congress, and 
make publicly available an updated Strategic Fed-
eral Plan to Improve Diagnosis that— 
(A) includes such updates as the Council 
determines to be appropriate; 
(B) includes information on the overall 
progress of the Federal Government in reducing 
barriers to research on, and supporting projects 
to improve, diagnosis in health care; and 
(C) includes administrative policy rec-
ommendations, and may include legislative rec-
ommendations, including addressing any needs 
for greater legislative authority to meet the ob-
jectives listed in subsection (b). 
VerDate Sep 11 2014 
16:30 Jul 03, 2022
Jkt 029200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H8172.IH
H8172
pbinns on DSKJLVW7X2PROD with $$_JOB
(e) AUTHORIZATION OF APPROPRIATIONS.—To carry 
out this section, there are authorized to be appropriated 
$1,500,000 for each of fiscal years 2023 through 2027. 
SEC. 7. NATIONAL ACADEMIES REPORT. 
(a) IN GENERAL.—The Director of the Agency for 
Healthcare Research and Quality shall seek to enter into 
a contract with the National Academies of Sciences, Engi-
neering, and Medicine under which such National Acad-
emies conducts a study and issues a report on disparities 
in diagnostic safety and quality that— 
(1) identifies what is known about the burden 
and causes of such disparities, including racial, eth-
nic, socioeconomic, age, gender, geography, language 
proficiency, and intersectional interactions; and 
(2) includes recommendations on specific ac-
tions that policymakers, researchers, clinicians, and 
other stakeholders can take to eliminate such bur-
dens. 
(b) AUTHORIZATION OF APPROPRIATIONS.—To carry 
out this section, there is authorized to be appropriated 
$1,500,000 for fiscal year 2023, to remain available until 
expended. 
Æ 
VerDate Sep 11 2014 
16:30 Jul 03, 2022
Jkt 029200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6301
E:\BILLS\H8172.IH
H8172
pbinns on DSKJLVW7X2PROD with $$_JOB